Bristol Myers Squibb-posted 3 months ago
$217,960 - $264,113/Yr
Full-time • Senior
Princeton, NJ
5,001-10,000 employees

The Director of Early Precision Medicine Regulatory Affairs leads global regulatory strategy for biomarkers and diagnostics, focusing on early-stage development through proof of concept and supporting registrations. This role establishes scalable frameworks for investigational assay development, ensuring timely, compliant submissions that support patient stratification in Phase I/II studies. As a key member of the Translational Medicine CLIA Laboratory Steering Committee, the director drives coordinated early-stage drug-diagnostic strategies and health authority engagement to accelerate access to precision therapies. The position demands deep scientific and regulatory expertise (US, EU, Canada, PMD, TGA or Global Devices/IVD preferred), cross-functional leadership, and a commitment to innovation in early precision medicine.

  • Drive the development and actively support the execution of innovative, compliant global regulatory strategies that enable cutting-edge biomarkers and diagnostic tests.
  • Design and operationalize a scalable regulatory framework within BMS that supports both internal investigational assay development and clinical specimen testing.
  • Serve as the regulatory lead on the Translational Medicine CLIA Laboratory Steering Committee, providing strategic guidance and hands-on execution in the design, development, and testing of investigational use assays.
  • Champion innovative regulatory strategies to resolve complex challenges and accelerate patient access.
  • Cultivate inclusive, high-impact collaboration with Precision Medicine, Research teams, Global and Regional Regulatory Leads, Global Regulatory Operations, and Quality.
  • Oversee global precision medicine submissions and health authority interactions.
  • Provide regulatory support on product partnership, vendor management and business development opportunities.
  • Serve as a strategic regulatory thought leader by actively shaping policy through trade association engagement.
  • Solid scientific background, PhD., M.D., PharmD, MS.
  • Significant experience in regulatory affairs and diagnostic-related development e.g., >8-10 years.
  • Deep expertise in global diagnostic development, including key markets such as US, EU, Canada, Australia, Japan, China submissions.
  • Extensive experience in designing regulatory strategies for companion diagnostics and biomarkers.
  • Proven ability to lead teams through complex health authority interactions and issue resolution.
  • Mastery of regulatory standards including GCP, GLP, CLIA, HIPAA, 21 CFR Parts 11, 312, 812, 820, ISO 13485, ISO 14971, EU IVDR, CMDR, TGA, PMDA, NMPA, and ICH guidelines.
  • Skilled in translating complex scientific and regulatory concepts into clear, actionable insights.
  • Demonstrates high personal accountability and excels in facilitation, negotiation, and strategic influence.
  • Experience with IHC, NGS, PCR, and/or mass spectrometry.
  • Experience in assay design through regulatory approval.
  • Medical, pharmacy, dental and vision care.
  • Wellbeing support such as the BMS Living Life Better program and employee assistance programs (EAP).
  • Financial well-being resources and a 401(K).
  • Financial protection benefits such as short- and long-term disability, life insurance, supplemental health insurance.
  • Work-life programs including paid national holidays and optional holidays, Global Shutdown Days, up to 120 hours of paid vacation.
  • Parental, caregiver, bereavement, and military leave.
  • Family care services such as adoption and surrogacy reimbursement, fertility/infertility benefits.
  • Tuition reimbursement and a recognition program.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service